{
    "Trade/Device Name(s)": [
        "ZYMUTEST HIA IgG",
        "ZYMUTEST HIA IgGAM"
    ],
    "Submitter Information": "Hyphen BioMed",
    "510(k) Number": "K071255",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003767",
        "K053559"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCO",
        "0545"
    ],
    "Summary Letter Date": "April 30, 2007",
    "Summary Letter Received Date": "May 10, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7695"
    ],
    "Regulation Name(s)": [
        "Platelet Factor 4 Radioimmunoassay"
    ],
    "Analyte Class(es)": [
        "immunology",
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Anti-Platelet Factor IV Complex Antibodies",
        "heparin-associated antibodies"
    ],
    "Specimen Type(s)": [
        "Plasma",
        "Serum"
    ],
    "Specimen Container(s)": [
        "Citrated tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Solid phase immunoassay"
    ],
    "Methodologies": [
        "Sandwich ELISA"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for ZYMUTEST HIA IgG and IgGAM ELISA kits for detection of anti-PF4 antibodies associated with heparin induced thrombocytopenia",
    "Indications for Use Summary": "In vitro diagnostic ELISA kit for laboratories to assist in screening patient samples for heparin-associated antibodies commonly found in heparin induced thrombocytopenia or thrombosis (HIT)",
    "fda_folder": "Hematology"
}